Phq-9 Quick Depression Assessment - Pfizer

The PHQ-9 Quick Depression Assessment by Pfizer is a self-report questionnaire used to assess the presence and severity of depression in individuals. It helps healthcare professionals in diagnosing and monitoring depression.

FAQ

Q: What is the PHQ-9?
A: The PHQ-9 is a quick depression assessment tool.

Q: Who developed the PHQ-9?
A: The PHQ-9 was developed by Pfizer.

Q: What is the purpose of the PHQ-9?
A: The purpose of the PHQ-9 is to assess the severity of depression.

Q: How does the PHQ-9 work?
A: The PHQ-9 consists of nine questions that ask about different symptoms of depression.

Q: Is the PHQ-9 used by healthcare professionals?
A: Yes, healthcare professionals often use the PHQ-9 to screen and monitor patients for depression.

Q: Is the PHQ-9 a diagnostic tool?
A: No, the PHQ-9 is not a diagnostic tool, but it can help indicate the presence and severity of depression.

Q: Can the PHQ-9 be used by individuals?
A: Yes, individuals can use the PHQ-9 as a self-assessment tool to evaluate their own depression symptoms.

Q: Should I rely solely on the PHQ-9 for a depression diagnosis?
A: No, the PHQ-9 should be used as part of a comprehensive assessment by a healthcare professional.

Q: What should I do If I score high on the PHQ-9?
A: If you score high on the PHQ-9, it is recommended to seek further evaluation and support from a healthcare professional.